[c09aa8]: / clusters / 9knumclustersv2 / clust_1405.txt

Download this file

186 lines (185 with data), 9.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
No current peripheral neuropathy > grade at time of randomization
Grade or greater peripheral neuropathy
Peripheral neuropathy Grade ?
Peripheral neuropathy of any etiology that exceeds grade
=< grade peripheral neuropathy
RE-REGISTRATION ELIGIBILITY CRITERIA (STEP ): =< grade peripheral neuropathy
Peripheral neuropathy >=
Grade >= peripheral neuropathy
Peripheral neuropathy ? Grade .
Grade >= peripheral neuropathy at the present time
Peripheral neuropathy of Grade within weeks prior to the first study therapy
Peripheral neuropathy ?grade .
Grade or greater peripheral neuropathy
Peripheral neuropathy >= grade at screening
Peripheral neuropathy > Grade despite supportive therapy.
Peripheral neuropathy of severity greater than grade
Peripheral neuropathy greater than or equal to Grade
Participants with >= grade peripheral neuropathy
Baseline peripheral neuropathy of severity > grade
Presence of >= grade peripheral neuropathy
Peripheral neuropathy >= grade
Presence of peripheral neuropathy > grade
Peripheral neuropathy =< grade at the time of registration
Presence of > grade peripheral neuropathy
Peripheral neuropathy >Grade
Grade >= peripheral neuropathy
Peripheral neuropathy > grade
Clinically significant (>= grade ) peripheral neuropathy at the time of study entry
Peripheral neuropathy grade >
Peripheral neuropathy > grade , except for grade without limitations on instrumental daily life activities;
Has greater than Grade peripheral sensory neuropathy or > Grade peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies.
Active >= grade peripheral neuropathy
Peripheral neuropathy > grade
Peripheral neuropathy grade or less.
No peripheral neuropathy
Baseline grade II peripheral neuropathy
Current peripheral neuropathy >= grade
Peripheral neuropathy >= grade at screening
Peripheral neuropathy grade or greater
Participants with baseline peripheral neuropathy greater than grade
Peripheral neuropathy >= grade
Baseline grade II peripheral neuropathy
ENTRECTINIB EXCLUSION CRITERIA: Peripheral neuropathy >= grade
Grade >= peripheral neuropathy at baseline (within days prior to cycle day )
No peripheral edema >= grade at baseline
No peripheral neuropathy >= grade at baseline
Peripheral neuropathy, if present, should be =< grade
Peripheral neuropathy > grade if due to brentuximab vedotin or any peripheral neuropathy > grade
Peripheral neuropathy grade -
Peripheral neuropathy > grade
Peripheral neuropathy >= grade
Has > Grade peripheral sensory neuropathy or > Grade peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies
Has history of Grade or greater peripheral neuropathy during the months prior to enrollment.
Patient with peripheral neuropathy Grade >
Grade >= peripheral neuropathy
Grade >= peripheral neuropathy
>= grade peripheral neuropathy
Peripheral neuropathy >= grade despite supportive therapy
Central nervous system (CNS) toxicity including peripheral neuropathy =< grade
Peripheral neuropathy of severity greater than grade
Greater than grade peripheral neuropathy at baseline
Peripheral neuropathy >= grade at baseline OR peripheral neuropathy >= grade I with neuropathic pain
Grade > peripheral neuropathy at baseline (within days prior to cycle day )
Subject has >= grade peripheral neuropathy
Peripheral neuropathy >= grade
Patients with > grade peripheral sensory neuropathy or > grade peripheral motor neuropathy graded according to the Modified (Balis) Pediatric Scale of Peripheral Neuropathies are not eligible
Peripheral neuropathy >= grade
Peripheral neuropathy >= grade
Peripheral neuropathy =< grade
>= grade peripheral neuropathy
>= grade peripheral neuropathy within days before beginning maintenance therapy
Peripheral neuropathy grade or greater
Has peripheral neuropathy ? Grade .
Peripheral neuropathy =< grade
Has peripheral neuropathy ? Grade
Subjects with baseline peripheral neuropathy that exceeds grade
Significant symptoms (grade >= ) peripheral neuropathy
Peripheral neuropathy ? Grade or ? Grade with pain within weeks prior to first dose
Peripheral neuropathy ? Grade
Peripheral neuropathy ? Grade .
Has peripheral neuropathy ? Grade
Current Grade > peripheral neuropathy
Grade ? peripheral neuropathy
Equal to or greater than grade ataxia, cranial or peripheral neuropathy
Peripheral neuropathy < grade
Grade >= peripheral neuropathy
Current Grade > peripheral neuropathy from any cause
Peripheral neuropathy exclusions
? Grade peripheral neuropathy
Baseline peripheral neuropathy/paresthesia grade >=
Patient has >= grade peripheral neuropathy
Patient has >= grade peripheral neuropathy
Serious peripheral neuropathy.
Peripheral neuropathy- grade or greater
Peripheral neuropathy ? Grade .
Peripheral neuropathy grade or greater
Participants who have more than grade peripheral neuropathy
Peripheral neuropathy >= grade
Peripheral neuropathy < grade
Clinically significant peripheral neuropathy
Has baseline peripheral neuropathy/paresthesia grade ? .
Evidence of peripheral neuropathy of Grade >.
Subject has peripheral neuropathy ? grade .
Peripheral neuropathy >= grade
Equal to or greater than grade ataxia, cranial or peripheral neuropathy
Grade or above peripheral neuropathy
Peripheral neuropathy: must be =< grade
Grade > peripheral neuropathy at baseline
Grade >= peripheral neuropathy within days prior to cycle day
Peripheral neuropathy =< grade at the time of registration
The patient has peripheral neuropathy >= grade
Grade >= peripheral neuropathy within days prior to initiation of therapy
Subject has peripheral neuropathy >= grade .
Peripheral neuropathy ? Grade despite supportive therapy
Has baseline peripheral neuropathy/paresthesia
Peripheral neuropathy > Grade .
Patient has >= grade peripheral neuropathy
Peripheral neuropathy greater than Grade
Peripheral neuropathy >= grade at baseline OR peripheral neuropathy >= grade I with neuropathic pain
No peripheral neuropathy greater than grade , due to any cause
Peripheral neuropathy: must be =< grade
Grade or more peripheral neuropathy
Peripheral neuropathy ? Grade
Peripheral neuropathy >= grade
No ? grade peripheral neuropathy.
Peripheral neuropathy =< grade
Peripheral neuropathy >= grade (Gr) II
Peripheral neuropathy =< grade
Grade peripheral neuropathy
Patient has >= grade peripheral neuropathy
Peripheral neuropathy
Peripheral neuropathy > grade
> grade peripheral neuropathy at baseline
Peripheral neuropathy of grade or greater
Presence of ? Grade peripheral neuropathy
Peripheral neuropathy ? Grade .
Presence of clinically significant non-hematological toxicity of prior chemotherapy that has not resolved to ? Grade as determined by CTCAE v ., with the exception of alopecia and peripheral neuropathy. Note: Peripheral neuropathy > Grade plus pain, or Grade or Grade are excluded.
Presence of > Grade peripheral neuropathy
Peripheral neuropathy ? Grade
Peripheral edema > grade
Baseline peripheral neuropathy ? grade .
Peripheral neuropathy ? grade .
Grade >= peripheral neuropathy
Peripheral neuropathy greater than grade
Evidence of peripheral neuropathy of Grade >
Subjects with > grade peripheral neuropathy
Peripheral neuropathy Grade >/=
Presence of peripheral neuropathy
Subjects with Grade > peripheral neuropathy
Peripheral neuropathy at study entry
Ongoing Grade or Grade peripheral neuropathy, or Grade peripheral neuropathy with pain despite appropriate interventions, within days prior to first dose of study treatment.
No grade >= peripheral neuropathy
Patient has >= grade peripheral neuropathy
Grade >= peripheral neuropathy
Baseline peripheral edema >= grade
Peripheral neuropathy ?Grade .
>= grade peripheral neuropathy
Peripheral neuropathy
Current Grade > peripheral neuropathy
History of peripheral neuropathy; (note: this does not apply to Cohort )
Grade >= peripheral neuropathy
Grade ? peripheral neuropathy at baseline (within days prior to cycle day ).
Grade or greater peripheral neuropathy
Peripheral neuropathy >= grade
Peripheral neuropathy that is greater or equal to Grade
Has peripheral neuropathy that is greater or equal to Grade
Patient has > Grade painful neuropathy or peripheral neuropathy
Peripheral neuropathy ? Grade
The participant has any Grade (or greater) peripheral neuropathy.
No grade or greater peripheral neuropathy.
History of peripheral neuropathy of ?grade
Peripheral neuropathy of > grade severity.
Peripheral neuropathy with grade =<
Clinically significant (>= grade ) peripheral neuropathy at the time of study entry
Peripheral neuropathy >= grade
Grade >= peripheral neuropathy
Any peripheral neuropathy >= grade
Grade III or IV upper extremity peripheral neuropathy
History of peripheral neuropathy prior to receiving neurotoxic chemotherapy
Pain or symptoms of peripheral neuropathy of > month's duration attributed to chemotherapy-induced peripheral neuropathy
Peripheral neuropathy greater than or equal to grade .
No >= grade peripheral neuropathy
Peripheral neuropathy ? grade
Peripheral neuropathy greater than grade
Peripheral neuropathy greater than grade